Richard Gelber
Richard Gelber
Professor, Harvard Medical School, Harvard TH Chan School of Public Health, Dana-Farber Cancer Institute, Frontier Science Foundation
Verified email at ds.dfci.harvard.edu
Title
Cited by
Cited by
Year
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart, M Procter, B Leyland-Jones, A Goldhirsch, M Untch, ...
New England Journal of Medicine 353 (16), 1659-1672, 2005
54972005
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 366 (9503), 2087-2106, 2005
49512005
Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
EM Connor, RS Sperling, R Gelber, P Kiselev, G Scott, MJ O'sullivan, ...
New England Journal of Medicine 331 (18), 1173-1180, 1994
48401994
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A Goldhirsch, WC Wood, AS Coates, RD Gelber, B Thürlimann, HJ Senn
Annals of oncology 22 (8), 1736-1747, 2011
35422011
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ...
Annals of oncology 24 (9), 2206-2223, 2013
27482013
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
I Smith, M Procter, RD Gelber, S Guillaume, A Feyereislova, M Dowsett, ...
The lancet 369 (9555), 29-36, 2007
17392007
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009
A Goldhirsch, JN Ingle, RD Gelber, AS Coates, B Thürlimann, HJ Senn
Annals of oncology 20 (8), 1319-1329, 2009
17002009
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ...
Annals of oncology 26 (8), 1533-1546, 2015
14902015
Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood
SE Lipshultz, SD Colan, RD Gelber, AR Perez-Atayde, SE Sallan, ...
New England Journal of Medicine 324 (12), 808-815, 1991
14621991
Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005
A Goldhirsch, JH Glick, RD Gelber, AS Coates, B Thürlimann, HJ Senn, ...
Annals of oncology 16 (10), 1569-1583, 2005
14332005
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
J Baselga, I Bradbury, H Eidtmann, S Di Cosimo, E De Azambuja, C Aura, ...
The Lancet 379 (9816), 633-640, 2012
12592012
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007
A Goldhirsch, WC Wood, RD Gelber, AS Coates, B Thürlimann, HJ Senn, ...
Annals of oncology 18 (7), 1133-1144, 2007
11502007
The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group
B Borgelt, R Gelber, S Kramer, LW Brady, CH Chang, LW Davis, ...
International Journal of Radiation Oncology* Biology* Physics 6 (1), 1-9, 1980
10721980
Analysis of survival by tumor response
JR Anderson, KC Cain, RD Gelber
J Clin Oncol 1 (11), 710-719, 1983
10691983
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor–positive …
EP Winer, C Hudis, HJ Burstein, AC Wolff, KI Pritchard, JN Ingle, ...
Journal of clinical oncology 23 (3), 619-629, 2005
10402005
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98
AS Coates, A Keshaviah, B Thurlimann, H Mouridsen, L Mauriac, ...
Journal of clinical oncology 25 (5), 486-492, 2007
10162007
Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.
BA Gusterson, RD Gelber, A Goldhirsch, KN Price, J Säve-Söderborgh, ...
Journal of Clinical Oncology 10 (7), 1049-1056, 1992
10161992
Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant
RS Sperling, DE Shapiro, RW Coombs, JA Todd, SA Herman, ...
New England Journal of Medicine 335 (22), 1621-1629, 1996
9771996
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
M Smith, D Arthur, B Camitta, AJ Carroll, W Crist, P Gaynon, R Gelber, ...
Journal of Clinical Oncology 14 (1), 18-24, 1996
9681996
Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer
A Goldhirsch, WC Wood, RD Gelber, AS Coates, B Thurlimann, HJ Senn
Journal of clinical oncology 21 (17), 3357-3365, 2003
9252003
The system can't perform the operation now. Try again later.
Articles 1–20